Nucleic Acids For Future Gene Editing, Immunotherapy and
Epigenetic Sequence Modification

NATURE-ETN will leverage recent breakthrough discoveries in epigenetic manipulation, gene editing, small molecule DNA targeting, and rapid gene/transgene detection to extend the boundaries of molecular medicine and provide new tools for treating cancer and monogenetic diseases.

We offer 15 ESRs a unique PhD experience with multidisciplinary scientific, business and transferable skills training and the chance to build a pan-European network with leading scientists in Europe.

Our network is comprised of ten beneficiaries and seven partner organisations from eight European countries, including nine leading research institutions, five cutting-edge SMEs and three multinationals. 

0
Partners
0
Countries
0
ESRs
0 M
Budget
0
Duration (months)